
- Volume 0 0
TAUZIN DEFENDS DIRECT-TO-CONSUMER Rx ADVERTISING
While the FDA takes a fresh look at theimpact of direct-to-consumer (DTC)advertising of prescription drugs, manufacturersof prescription medicines saythe evidence supporting the value ofthese ads is clear-cut. "There is no doubtthat DTC advertising is an invaluable communicationstool that empowers millionsof Americans to talk to health care professionalsabout their medical conditions," Pharmaceutical Research andManufacturers of America President andChief Executive Officer Billy Tauzin said.
Tauzin, a former congressman activelyinvolved in health care issues, arguedthat consumer ads for prescription productsgive physicians an opportunity todiscuss the risks and benefits of coursesof treatments—a dialogue that producesmore informed patients.
"The educational value of DTC advertisingis particularly important to addressunderdiagnosis and undertreatment ofmajor medical conditions such as asthma,cerebral vascular disease, diabetes,and hypertension," he said.
Articles in this issue
almost 20 years ago
Resealable and Nultraviolet Ultraviolet (UV) Inhibitant Bagsalmost 20 years ago
High Alert Insulin Binalmost 20 years ago
Hydase (hyaluronidase injection, USP)almost 20 years ago
Humira (adalimumab)almost 20 years ago
INVANZ (ertapenem for injection)almost 20 years ago
Compounding HOTLINEalmost 20 years ago
Customer Guilty of Prescription Fraud by Supporting Friendalmost 20 years ago
Counterfeit Drugs: A Life-or-Death Problemalmost 20 years ago
Qui Tam Lawsuits Blow the Whistle on PBMsalmost 20 years ago
Can You Read These Rxs?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.